Lista de obras -

A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema

artículo científico publicado en 2019

A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer

scientific article published on 08 October 2019

A review of interventional clinical trials in renal cell carcinoma: a status report from the ClinicalTrials.gov WebSite.

artículo científico publicado en 2014

Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis

artículo científico publicado en 2017

Anti-angiogenesis in prostate cancer: knocked down but not out

artículo científico publicado en 2014

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

scientific article published on 01 December 2020

Cabazitaxel: a new drug for metastatic prostate cancer ⬇️

artículo científico publicado el 13 de diciembre de 2010

Cabozantinib plus Docetaxel and Prednisone in Metastatic Castrate Resistant Prostate Cancer

artículo científico publicado en 2020

Cancer Vaccines

artículo científico publicado en 2019

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.

artículo científico

Clinical evaluation of TRICOM vector therapeutic cancer vaccines

artículo científico publicado en 2012

Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions.

artículo científico publicado en 2017

Early adolescence and suicidal ideations in Croatia: sociodemographic, behavioral, and psychometric correlates.

artículo científico publicado en 2011

Editorial: Local Immunotherapy: A Way to Convert Tumors From "Cold" to "Hot"

artículo científico publicado en 2017

Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines

artículo científico publicado en 2012

First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors

scientific article published on 21 August 2018

Immunotherapy of Prostate Cancer: Facts and Hopes.

artículo científico publicado en 2017

Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy?

artículo científico publicado en 2014

Mapping the Genetic Determinants of Hypertension, Metabolic Diseases, and Related Phenotypes in the Lyon Hypertensive Rat

artículo científico publicado en 2004

Molecular Profiling of Exceptional Responders to Cancer Therapy

artículo científico publicado en 2020

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report

scientific article published on 18 December 2018

Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.

artículo científico publicado en 2018

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

artículo científico publicado en 2016

Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date

artículo científico publicado en 2020

Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors

artículo científico publicado en 2019

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors

scientific article published on 05 September 2019

Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma.

artículo científico publicado en 2013

Plasmapheresis in the treatment of hypertriglyceridemia-induced pancreatitis: A community hospital's experience

artículo científico publicado en 2010

Provider and patient burdens of obtaining oral anticancer medications

artículo científico publicado en 2018

Recurrent bulbar paralysis caused by botulinum toxin type B

artículo científico publicado en 2008

Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer

artículo científico publicado en 2016

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-Risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is predictive of therapeutic response

scientific article published on 06 October 2020

Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review.

artículo científico publicado en 2016

Spontaneous tumor lysis syndrome in renal cell carcinoma: a case report.

artículo científico publicado en 2014

Therapeutic cancer vaccines in prostate cancer: the quest for intermediate markers of response.

artículo científico publicado en 2012

Therapeutic cancer vaccines: the latest advancement in targeted therapy

artículo científico publicado en 2012

TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy

artículo científico publicado en 2016

mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy

artículo científico publicado en 2019

Lista de obras de

A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema

A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer

A review of interventional clinical trials in renal cell carcinoma: a status report from the ClinicalTrials.gov WebSite.

Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis

Anti-angiogenesis in prostate cancer: knocked down but not out

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Cabazitaxel: a new drug for metastatic prostate cancer ⬇️

Cabozantinib plus Docetaxel and Prednisone in Metastatic Castrate Resistant Prostate Cancer

Cancer Vaccines

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.

Clinical evaluation of TRICOM vector therapeutic cancer vaccines

Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions.

Early adolescence and suicidal ideations in Croatia: sociodemographic, behavioral, and psychometric correlates.

Editorial: Local Immunotherapy: A Way to Convert Tumors From "Cold" to "Hot"

Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines

First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors

Immunotherapy of Prostate Cancer: Facts and Hopes.

Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy?

Mapping the Genetic Determinants of Hypertension, Metabolic Diseases, and Related Phenotypes in the Lyon Hypertensive Rat

Molecular Profiling of Exceptional Responders to Cancer Therapy

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report

Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date

Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors

Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma.

Plasmapheresis in the treatment of hypertriglyceridemia-induced pancreatitis: A community hospital's experience

Provider and patient burdens of obtaining oral anticancer medications

Recurrent bulbar paralysis caused by botulinum toxin type B

Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-Risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is predictive of therapeutic response

Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review.

Spontaneous tumor lysis syndrome in renal cell carcinoma: a case report.

Therapeutic cancer vaccines in prostate cancer: the quest for intermediate markers of response.

Therapeutic cancer vaccines: the latest advancement in targeted therapy

TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy

mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy